GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetics Generation Advancement Corp (ROCO:4160) » Definitions » COGS-to-Revenue

Genetics Generation Advancement (ROCO:4160) COGS-to-Revenue : 0.58 (As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Genetics Generation Advancement COGS-to-Revenue?

Genetics Generation Advancement's Cost of Goods Sold for the three months ended in Mar. 2025 was NT$82.6 Mil. Its Revenue for the three months ended in Mar. 2025 was NT$143.4 Mil.

Genetics Generation Advancement's COGS to Revenue for the three months ended in Mar. 2025 was 0.58.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Genetics Generation Advancement's Gross Margin % for the three months ended in Mar. 2025 was 42.41%.

Genetics Generation Advancement COGS-to-Revenue Historical Data

The historical data trend for Genetics Generation Advancement's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetics Generation Advancement COGS-to-Revenue Chart

Genetics Generation Advancement Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 0.62 0.59 0.60 0.58

Genetics Generation Advancement Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.55 0.56 0.60 0.58

Genetics Generation Advancement COGS-to-Revenue Calculation

Genetics Generation Advancement's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=381.844 / 661.855
=0.58

Genetics Generation Advancement's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=82.572 / 143.369
=0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetics Generation Advancement  (ROCO:4160) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Genetics Generation Advancement's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 82.572 / 143.369
=42.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Genetics Generation Advancement COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genetics Generation Advancement's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetics Generation Advancement Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetics Generation Advancement Corp (ROCO:4160) » Definitions » COGS-to-Revenue
Comparable Companies
ROCO:6847 TPE:6645 ROCO:6939 ROCO:6615 ROCO:7595 ROCO:6661 ROCO:4153 ROCO:1784 TMO DHR XSWX:LONN IDXX A SHSE:603259 IQV MTD NTRA WAT LH DGX
Traded in Other Exchanges
N/A
Address
No. 28, Lane 36, Xinhu 1st Road, 6th Floor, Neihu District, Taipei, TWN, 11494
Website
https://www.gga.asia
Genetics Generation Advancement Corp is a Taiwan based company specialized in genetic testing and scientific information. It is engaged in providing services for the detection of genetic defects and prevention in newborns. Their main services include amniotic fluid chromosome chip screening, pre-implantation genetic diagnosis, and Molecular DNA testing diagnostics. The company is focused on the majority of areas of maternal precision medicine, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection, and precise health management. The business units of the company are the Genetic Testing Unit and Informatics business unit.

Genetics Generation Advancement Headlines

No Headlines